Publicaciones (45) Publicaciones de Alfonso Otero González

2024

  1. Proceso asistencial integrado enfermedad renal crónica (ERC)

    Conselleria de Sanidade

2023

  1. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature

    Chronobiology International, Vol. 40, Núm. 1, pp. 63-82

  2. Sindrome nefrótico y embarazo

    Hipertensión y riesgo vascular, Vol. 40, Núm. 1, pp. 1-4

2021

  1. Ambulatory blood pressure monitoring-based definition of true arterial hypertension

    Minerva Medica, Vol. 111, Núm. 6, pp. 573-588

  2. Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961

  3. Guidelines for the design and conduct of human clinical trials on ingestion-time differences–chronopharmacology and chronotherapy–of hypertension medications

    Chronobiology International, Vol. 38, Núm. 1, pp. 1-26

  4. Hemodialysis Centers Guide 2020

    Nefrologia, Vol. 41, pp. 1-77

  5. Protein Extraction From FFPE Kidney Tissue Samples: A Review of the Literature and Characterization of Techniques

    Frontiers in Medicine, Vol. 8

2020

  1. Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.

    Chronobiology International, pp. 1-10

  2. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

    European heart journal, Vol. 41, Núm. 48, pp. 4565-4576

  3. Does Timing of Antihypertensive Medication Dosing Matter?

    Current Cardiology Reports, Vol. 22, Núm. 10

  4. New perspectives on the definition, diagnosis, and treatment of true arterial hypertension

    Expert Opinion on Pharmacotherapy, Vol. 21, Núm. 10, pp. 1167-1178

2019

  1. Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk

    European Heart Journal

  2. Prospective randomized multicenter study to demonstrate the benefits of haemodialysis without acetate (with citrate): ABC-treat Study. Acute effect of citrate

    Nefrologia, Vol. 39, Núm. 4, pp. 424-433

2018

  1. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention

    European Heart Journal, Vol. 39, Núm. 47, pp. 4159-4171

2015

  1. Survival for haemodialysis vs. peritoneal dialysis and technique transference: Experience in Ourense, Spain, from 1976 to 2012

    Nefrologia, Vol. 35, Núm. 6, pp. 562-566

2013

  1. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals

    Chronobiology International, Vol. 30, Núm. 3, pp. 355-410

  2. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 159-175

  3. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 145-158

  4. Recomendaciones 2013 para el uso de la monitorización ambulatoria de la presión arterial para el diagnóstico de hipertensión en adultos, valoración de riesgo cardiovascular y obtención de objetivos terapéuticos (resumen). Recomendaciones conjuntas de la International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Sociedad Española de Cronobiología Aplicada, Cronoterapia y Riesgo Vascular (SECAC), Sociedad Española de Arteriosclerosis (SEA) y Romanian Society of Internal Medicine (RSIM)

    Clínica e investigación en arteriosclerosis, Vol. 25, Núm. 2, pp. 74-82